日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / Europe

More countries pause vaccine roll-out for fear of potential clot risks

By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-17 09:30
Share
Share - WeChat
Vials labelled with partially torn sticker "AstraZeneca COVID-19 Coronavirus Vaccine" are seen in front of a displayed EU flag in this illustration taken March 15, 2021. [Photo/Agencies]

Officials from the United Nations and European Union are to hold talks as the temporary suspension of deployment of the AstraZeneca novel coronavirus vaccine continues to spread across the EU, because of fears that it may be connected to cases of blood clotting.

Its suspension, said Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, or WHO, "does not necessarily mean these events are linked to vaccination, but it's routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place".

At the same time as EU countries are increasingly expressing doubts about the vaccine made by the Anglo-Swedish pharmaceutical company, European Commission President Ursula von der Leyen has announced a deal for what she called the "accelerated delivery" of 10 million doses of the vaccine developed by BioNTech and Pfizer, for the second quarter of the year.

"This will bring the total deliveries of this vaccine to 200 million doses for that quarter," she tweeted. "It will give (EU) Member States room to manoeuvre and possibly fill gaps in deliveries."

Germany, France, Portugal and Spain have become the latest countries to join a growing list of countries that have called a temporary halt to use of the vaccine, despite reassurances from the European Medicines Agency, or EMA, that there is no link between the vaccine and a small number of cases of people who developed blood clots after receiving it.

Germany's Health Minister Jens Spahn said the "precautionary" measure was taken after consultation with national health regulator, the Paul Ehrlich Institute (PEI), adding that "the decision is a professional, not political one" and that any further decision on its use would be made based on new information coming from the EMA.

"After new reports of thrombroses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," said a statement from the health ministry. "The most important thing for confidence is transparency," Spahn added.

French President Emmanuel Macron also announced a temporary halt to its use on Monday. "The decision that was taken, in accordance with our European policy, is to suspend as a precaution the vaccination with AstraZeneca, hoping to resume it as soon as possible if the opinion is favorable," he explained. Macron made the comments at a Franco-Spanish summit, which took place as Spain too stopped using the vaccine for at least a fortnight.

The WHO said on Monday that its Global Advisory Committee on Vaccine Safety would meet on Tuesday, and has been in close contact with the EMA, which has in turn said it will make an announcement about the AstraZeneca vaccine on Thursday, which it hopes will bring the matter to a conclusion.

"EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects," the organization said in a statement.

Better news for AstraZeneca has come from Australia, where the country's chief medical officer, Paul Kelly, says there is no link between the vaccine and blood clots.

However, the only vaccine manufacturer in the country, CSL, has said it is in talks with the Australian government about producing alternatives to the AstraZeneca jab.

"While CSL remains open to discussions about manufacture of alternative COVID-19 vaccines, our resources are fully committed to the manufacture of the AstraZeneca vaccine," the company's chief scientific officer, Andrew Nash, told The Guardian.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 日韩在线观看视频一区二区三区 | 久久精品免费网站 | 亚洲欧美综合人成野草 | 91热久久免费频精品黑人99 | 天天拍天天干 | 9277在线观看视频 | 免费a网站 | 久久婷婷影院 | 日韩欧美一区二区三区免费观看 | 午夜影院在线视频 | 久久久一区二区 | 夜夜操网| 精品久久九九 | 国产在线不卡 | 国产目拍亚洲精品99久久精品 | 亚洲一区免费看 | 精品综合| 欧美日韩一区二区综合在线视频 | 中文字幕 国产精品 | 日本一区二区三区中文字幕 | 7777精品伊人久久久大香线蕉 | 国产999精品久久久影片官网 | 国产精品成人观看视频国产 | 天天艹天天 | 青草草在线观看免费视频 | 欧美成人手机在线 | 日本午夜免费无码片三汲大片 | 午夜精品久久久久久91 | 日本黄色不卡视频 | 国产午夜精品一区二区三区嫩草 | 综合导航| 91看片在线观看 | 奇米影视第四色av首页 | 欧美亚洲 尤物久久 综合精品 | 陈宝莲a毛片在线播放 | 欧美人成在线视频 | 99久久精品国产片久人 | 四虎影业 | 91短视频免费在线观看 | 91国内精品久久久久免费影院 | 日韩亚洲欧美中文高清在线 |